• Je něco špatně v tomto záznamu ?

Myo-Inositol Levels in the Dorsal Hippocampus Serve as Glial Prognostic Marker of Mild Cognitive Impairment in Mice

T. Ebert, DE. Heinz, S. Almeida-Corrêa, R. Cruz, F. Dethloff, T. Stark, T. Bajaj, OM. Maurel, FM. Ribeiro, S. Calcagnini, K. Hafner, NC. Gassen, CW. Turck, B. Boulat, M. Czisch, CT. Wotjak

. 2021 ; 13 (-) : 731603. [pub] 20211112

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001312

Dementia is a devastating age-related disorder. Its therapy would largely benefit from the identification of susceptible subjects at early, prodromal stages of the disease. To search for such prognostic markers of cognitive impairment, we studied spatial navigation in male BALBc vs. B6N mice in combination with in vivo magnetic resonance spectroscopy (1H-MRS). BALBc mice consistently showed higher escape latencies than B6N mice, both in the Water Cross Maze (WCM) and the Morris water maze (MWM). These performance deficits coincided with higher levels of myo-inositol (mIns) in the dorsal hippocampus before and after training. Subsequent biochemical analyses of hippocampal specimens by capillary immunodetection and liquid chromatography mass spectrometry-based (LC/MS) metabolomics revealed a higher abundance of glial markers (IBA-1, S100B, and GFAP) as well as distinct alterations in metabolites including a decrease in vitamins (pantothenic acid and nicotinamide), neurotransmitters (acetylcholine), their metabolites (glutamine), and acetyl-L-carnitine. Supplementation of low abundant acetyl-L-carnitine via the drinking water, however, failed to revert the behavioral deficits shown by BALBc mice. Based on our data we suggest (i) BALBc mice as an animal model and (ii) hippocampal mIns levels as a prognostic marker of mild cognitive impairment (MCI), due to (iii) local changes in microglia and astrocyte activity, which may (iv) result in decreased concentrations of promnesic molecules.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001312
003      
CZ-PrNML
005      
20220112153546.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnagi.2021.731603 $2 doi
035    __
$a (PubMed)34867270
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Ebert, Tim $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany $u Research Group Neurohomeostasis, Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany
245    10
$a Myo-Inositol Levels in the Dorsal Hippocampus Serve as Glial Prognostic Marker of Mild Cognitive Impairment in Mice / $c T. Ebert, DE. Heinz, S. Almeida-Corrêa, R. Cruz, F. Dethloff, T. Stark, T. Bajaj, OM. Maurel, FM. Ribeiro, S. Calcagnini, K. Hafner, NC. Gassen, CW. Turck, B. Boulat, M. Czisch, CT. Wotjak
520    9_
$a Dementia is a devastating age-related disorder. Its therapy would largely benefit from the identification of susceptible subjects at early, prodromal stages of the disease. To search for such prognostic markers of cognitive impairment, we studied spatial navigation in male BALBc vs. B6N mice in combination with in vivo magnetic resonance spectroscopy (1H-MRS). BALBc mice consistently showed higher escape latencies than B6N mice, both in the Water Cross Maze (WCM) and the Morris water maze (MWM). These performance deficits coincided with higher levels of myo-inositol (mIns) in the dorsal hippocampus before and after training. Subsequent biochemical analyses of hippocampal specimens by capillary immunodetection and liquid chromatography mass spectrometry-based (LC/MS) metabolomics revealed a higher abundance of glial markers (IBA-1, S100B, and GFAP) as well as distinct alterations in metabolites including a decrease in vitamins (pantothenic acid and nicotinamide), neurotransmitters (acetylcholine), their metabolites (glutamine), and acetyl-L-carnitine. Supplementation of low abundant acetyl-L-carnitine via the drinking water, however, failed to revert the behavioral deficits shown by BALBc mice. Based on our data we suggest (i) BALBc mice as an animal model and (ii) hippocampal mIns levels as a prognostic marker of mild cognitive impairment (MCI), due to (iii) local changes in microglia and astrocyte activity, which may (iv) result in decreased concentrations of promnesic molecules.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Heinz, Daniel E $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany $u Max Planck School of Cognition, Leipzig, Germany
700    1_
$a Almeida-Corrêa, Suellen $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Cruz, Renata $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Dethloff, Frederik $u Proteomics and Biomarkers, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Stark, Tibor $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czechia $u Scientific Core Unit "Neuroimaging", Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Bajaj, Thomas $u Research Group Neurohomeostasis, Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany
700    1_
$a Maurel, Oriana M $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Ribeiro, Fabiola M $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Calcagnini, Silvio $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Hafner, Kathrin $u Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Gassen, Nils C $u Research Group Neurohomeostasis, Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany $u Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Turck, Christoph W $u Proteomics and Biomarkers, Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Boulat, Benoit $u Scientific Core Unit "Neuroimaging", Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Czisch, Michael $u Scientific Core Unit "Neuroimaging", Max Planck Institute of Psychiatry, Munich, Germany
700    1_
$a Wotjak, Carsten T $u Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany $u Central Nervous System Diseases Research (CNSDR), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
773    0_
$w MED00174539 $t Frontiers in aging neuroscience $x 1663-4365 $g Roč. 13, č. - (2021), s. 731603
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34867270 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153542 $b ABA008
999    __
$a ind $b bmc $g 1745434 $s 1152459
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c - $d 731603 $e 20211112 $i 1663-4365 $m Frontiers in aging neuroscience $n Front Aging Neurosci $x MED00174539
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Možnosti archivace